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Background: Alterations in skeletal muscle contractile activity necessitate an efficient remodeling mechanism. In
particular, mitochondrial turnover is essential for tissue homeostasis during muscle adaptations to chronic use and
disuse. While mitochondrial biogenesis appears to be largely governed by the transcriptional co-activator peroxisome
proliferator co-activator 1 alpha (PGC-1α), selective mitochondrial autophagy (mitophagy) is thought to mediate
organelle degradation. However, whether PGC-1α plays a direct role in autophagy is currently unclear.
Methods: To investigate the role of the co-activator in autophagy and mitophagy during skeletal muscle remodeling,
PGC-1α knockout (KO) and overexpressing (Tg) animals were unilaterally denervated, a common model of chronic
muscle disuse.
Results: Animals lacking PGC-1α exhibited diminished mitochondrial density alongside myopathic characteristics
reminiscent of autophagy-deficient muscle. Denervation promoted an induction in autophagy and lysosomal protein
expression in wild-type (WT) animals, which was partially attenuated in KO animals, resulting in reduced autophagy
and mitophagy flux. PGC-1α overexpression led to an increase in lysosomal capacity as well as indicators of autophagy
flux but exhibited reduced localization of LC3II and p62 to mitochondria, compared to WT animals. A correlation was
observed between the levels of the autophagy-lysosome master regulator transcription factor EB (TFEB) and PGC-1α in
muscle, supporting their coordinated regulation.
Conclusions: Our investigation has uncovered a regulatory role for PGC-1α in mitochondrial turnover, not only
through biogenesis but also via degradation using the autophagy-lysosome machinery. This implies a PGC-1α-
mediated cross-talk between these two opposing processes, working to ensure mitochondrial homeostasis during
muscle adaptation to chronic disuse.
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Skeletal muscle is the largest organ of the body and as
such is recognized for essential roles that extend beyond
locomotion. Muscle is an indispensable metabolic center
that possesses a remarkable capacity to adapt to alter-
ations in its milieu, a property known as muscle plasticity.
This type of malleability to cues such as contraction, nu-
trient availability, or hormonal stimuli requires efficient
cellular remodeling and a rapid shift in metabolic profile.
Since mitochondria are central to muscle metabolism,
these types of alterations require amendments in organelle
content and its network. Mitochondrial density depends* Correspondence: dhood@yorku.ca
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unless otherwise stated.on the intricate balance between biogenesis and degrad-
ation. Biogenesis is largely regulated transcriptionally
through the coordinate expression of nuclear and mito-
chondrial genes, governed by the transcriptional co-
activator peroxisome proliferator gamma coactivator-1α
(PGC-1α) [1]. On the other hand, mitochondrial degrad-
ation is achieved through a selective form of macroauto-
phagy (hereafter autophagy) termed mitophagy [2]. This
process is of particular importance for long-lived post-
mitotic tissues such as the striated muscle and neurons, as
this represents the sole mechanism for these cells to rid
themselves of dysfunctional organelles. During mitophagy,
the defective mitochondria are first segregated from the
network and are then engulfed into double-membrane
vesicles termed autophagosomes [3], which aretral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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degradation.
Mitochondrial health is vital not only for proficient en-
ergy provision but also for proper cellular signaling and
homeostasis, as mitochondria are often found at the ful-
crum of cellular life-and-death decisions [4]. Thus, it is
not surprising that mitochondrial abnormalities have
been implicated in a plethora of muscle wasting condi-
tions such as the sarcopenia of aging [5], pathology-
related cachexia, [6] and various muscular dystrophies
[7-9]. Interestingly, the skeletal muscle from animals
with autophagic deficiencies closely resembles that of
sarcopenic and atrophic patients [10]. Thus, the intrica-
cies underlying mitochondrial remodeling in the skeletal
muscle have great therapeutic potential for a myriad of
debilitating conditions. While mitophagy is important
for proper tissue remodeling and organelle turnover, the
regulation of this process in the skeletal muscle remains
largely elusive.
PGC-1α, which is most well recognized for its role in
mitochondrial biogenesis, has been documented to spare
muscle mass and improve endurance in atrophic muscle
induced by senescence [11], chronic heart failure [12],
and a variety of additional muscle wasting conditions
[13,14]. More recently, PGC-1α has been implicated in
the autophagy-lysosome pathway, and its overexpression
was demonstrated to induce lysosomal biogenesis, pos-
sibly through the upregulation of transcription factor EB
(TFEB) [15-17], a transcription factor that is a master
regulator of the lysosomal system. However, the role of
PGC-1α in mitochondrial removal and autophagy in the
skeletal muscle has not been thoroughly examined. To
this end, the purpose of this study was to examine the
possibility of a coordinated regulation of mitochondrial re-
modeling by the metabolic master regulator PGC-1α in
the skeletal muscle. Here, we investigate the involvement
of PGC-1α in basal and denervation-induced autophagy
using both gain- and loss-of-function approaches. Our re-
sults implicate PGC-1α in the regulation of the mitochon-
drial network, not only via biogenesis but also through
degradation.
Methods
Animal generation, procedures, and treatment
The generation and characterization of PGC-1α knockout
(KO) and PGC-1α transgenic (Tg) mice have been de-
scribed in detail elsewhere [13,18-20]. PGC-1α whole-
body KO animals were generated by Lin et al. as described
previously [18]. For PGC-1α Tg mice, the transgene was
expressed specifically in the muscle under the control of
muscle creatine kinase (MCK) promoter. All mice were
housed in a 12:12-h light-to-dark cycle and given food and
water ad libitum. Where indicated, the animals were uni-
laterally denervated by severing the sciatic nerve aspreviously described [21], while the contralateral limb
served as an internal control. To assess autophagy flux,
the animals were treated with either colchicine or an equal
volume of vehicle (water) through an intraperitoneal injec-
tion every 24 h at a dose of 0.4 mg/kg/day [22] for the last
4 days of denervation, with the final injection taking place
24 h prior to sacrifice. Following 7 days of denervation,
the muscles were harvested and either immediately frozen
for histology, protein, and gene expression analysis or used
for cellular fractionation. Extensor digitorum longus
(EDL) muscles were fixed for single fiber analysis or elec-
tron microscopy. All procedures involving PGC-1α KO
and corresponding wild-type (WT) animals were ap-
proved by and conducted in accordance with the regula-
tions of the York University Animal Care Committee in
compliance with the guidelines set forth by the Canadian
Council on Animal Care. All PGC-1α Tg and correspond-
ing WT procedures were approved and authorized by the
Italian Ministry of Health.Histology and cross sectional area
Cytochrome oxidase (COX) and succinate dehydrogenase
(SDH) staining was performed on 10-μm cross sections of
digitorum longus (EDL) and tibialis anterior (TA) muscles
as previously described [23]. Fiber cross-sectional area
(CSA) of individual muscle fibers was determined using
Image J software (NIH, Bethesda, MD, USA) by a blinded
investigator. Fiber sizes were expressed in micrometers
squared.COX activity
COX enzyme activity was measured as previously de-
tailed [24] by determining the maximal rate of oxida-
tion of fully reduced cytochrome c, evaluated as a
change in absorbance at 550 nm using a microplate
reader (Bio-Tek Synergy HT, BioTek Instruments, Inc.,
Winooski, VT, USA).Electron microscopy
Tissue preparation for electron microscopy (EM) was
performed as previously described [25]. Briefly, sections
of EDL muscles from WT and KO animals were fixed
for 1 h in 3.0% glutaraldehyde followed by a 1-h fix-
ation in 1% osmium tetroxide diluted in 0.1 M sodium
cacodylate at room temperature. The muscle sections
were dehydrated and embedded in Epon resin, sliced
into ultrathin (60-nm) sections, and stained with uranyl
acetate and lead citrate. Electron micrographs were ob-
tained using a Philips EM201 electron microscope (Philips,
Amsterdam, The Netherlands).
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Quantitative real-time PCR was performed to determine
mRNA expression levels. Total RNA was isolated using
TRIzol reagent (Invitrogen, 15596-026, Life Technolo-
gies, Grand Island, NY, USA). RNA was reverse tran-
scribed into cDNA using a Superscript III first strand
synthesis kit (Invitrogen, 18080-044) according to manu-
facturer instructions. The primers used for gene expression
analysis are listed in Additional file 1: Table S1 and were
designed based on sequences available in GenBank (http://
www.ncbi.nlm.nih.gov/entrez/query.fcgi). Analyses were
performed with SYBR® Green chemistry (PerfeCTa SYBR®
Green Supermix, ROX, Quanta BioSciences, 95055-500;
Quanta BioSciences Inc., Gaithersburg, MD, USA) in a Ste-
pOnePlus™ Real-Time PCR System (Applied Biosystems
Inc., Foster City, CA, USA). Gapdh and Actb were used in
combination as housekeeping genes.
Immunoblotting
Protein extracts from frozen TA cryosections [26], iso-
lated mitochondria, or nuclear extracts were separated
by SDS-PAGE and transferred to nitrocellulose mem-
branes, which were blocked with 5% skim milk or 5%
BSA solution. Membranes were incubated overnight at
4°C with the appropriate concentration of primary anti-
body (see Additional file 1: Table S2 for a full list of anti-
bodies). Membranes were subsequently washed and
incubated with the suitable HRP-conjugated secondary
antibody for 1 h at room temperature and visualized
with enhanced chemiluminescence. Quantification was
performed with Image J Software (NIH, Bethesda, MD,
USA), and values were normalized to the appropriate
loading control.
Single fiber immunofluorescence
Immunofluorescence staining was performed on isolated
fixed EDL fibers [27] and imaged using a confocal
microscope. Briefly, freshly excised EDL muscles were
anchored at both ends and fixed with 2% paraformalde-
hyde in phosphate buffer for 1 h at room temperature.
The muscles were then washed with PBS, kept in 50%
glycerol at 4°C overnight, and were subsequently trans-
ferred to −20°C and stored until further use. The mus-
cles were gradually transitioned through diminishing
concentrations of glycerol, and individual fibers were
then mechanically teased apart in a puddle of 0.04% sap-
onin. The fibers were mounted onto glass slides and
permeabilized with 0.2% Triton X-100 in 10% goat
serum in PBS blocking solution. The fibers were then
co-incubated overnight at 4°C with the appropriate pri-
mary antibodies (Additional file 1: Table S2) diluted in
blocking solution. The fibers were washed with PBS and
then co-incubated with the suitable fluorescent second-
ary antibodies for 2 h at room temperature. The fiberswere subsequently washed three times with PBS, and
DAPI was added to the first wash at a 0.5 μg/ml concen-
tration in order to visualize the myonuclei. Glass cover
slips were mounted onto the slides with DPX Mountant
for histology (Fluka, 44581; Sigma-Aldrich, St. Louis, MO,
USA) and sealed. Images were acquired with an Olympus
Fluoview confocal microscope equipped with a × 60 ob-
jective (Olympus Corporation, Shinjuku, Tokyo, Japan).
Cellular fractionation
Enriched mitochondrial and nuclear cellular subfractions
were isolated by differential centrifugation, as previously
described [24]. Briefly, the muscles were minced on ice and
homogenized using a Teflon pestle and mortar and sus-
pended in mitochondrial isolation buffer (MIB; 250 mM
Sucrose, 20 mM HEPES, 10 mM KCl, 1.5 mM MgCl2,
1 mM EDTA, 1 mM EGTA) supplemented with protease
(Complete, Roche, 1169749801; Roche Diagnostics, Basel,
Switzerland) and phosphatase inhibitor cocktails (Cocktail
2 and 3, Sigma, P5726 and P0044). The homogenates were
then centrifuged at 1,000 g for 10 min at 4°C to pellet the
nuclei while mitochondrial and cytosolic fractions were
contained within the supernate. The supernate fraction
was re-centrifuged at 16,000 g for 20 min at 4°C to pellet
the mitochondria. The mitochondrial pellet was washed
twice and resuspended in a onefold dilution of MIB. Mito-
chondria were subsequently sonicated 3 × 3 s to yield the
enriched mitochondrial fraction. Pellets containing nuclei
were re-suspended in nuclear lysis buffer (1.5 mM MgCl2,
0.2 mM EDTA, 20 mM HEPES, 0.5 M NaCl, 20% glycerol,
1% Triton-X-100), incubated on ice for 30 min, and then
sonicated 3 × 10 s followed by a final centrifugation step
of 15 min at 16,000 g. The supernate was collected to ob-
tain the enriched nuclear fraction. Protein concentrations
within the samples were determined using the Bradford
method. Fraction purity was determined by western blot
analysis (Additional file 1: Figure S3).
Statistics
Comparisons between WT and KO or TG and control
(Con) and denervated (Den) animals were evaluated
using two-way analyses of variance (ANOVA) on each of
the treatment conditions. Bonferroni post-tests were
performed when applicable. All values represent the
mean ± SE. Data were considered statistically different if
P < 0.05.Results
Lack of PGC-1α results in diminished mitochondrial content,
reduced muscle mass, and a myopathic phenotype
In order to ascertain the role of PGC-1α in skeletal
muscle autophagy, 8-month-old whole-body PGC-1α
KO and WT animals were unilaterally denervated for
Vainshtein et al. Skeletal Muscle  (2015) 5:9 Page 4 of 177 days by severing the sciatic nerve of one hindlimb,
with the contralateral limb serving as an internal Con.
Denervation resulted in similar reductions in muscle
mass in both WT and KO animals (Figure 1A). When
corrected for body weight, the muscle mass of KO ani-
mals was greater than that of the WT littermates; how-
ever this was a result of their reduced body weight and
not due to muscle hypertrophy, as fiber cross-sectional
areas were smaller in mice lacking PGC-1α (Additional
file 1: Figure S1A-C). Basal mitochondrial content was
significantly diminished in KO animals, as evidenced
from the reduced intensity of COX and SDH staining, as
well as a lower COX activity measured biochemically
(Figure 1B,C,D). Denervation resulted in 33% and 42%
decrease in mitochondrial content in WT and KO mice,
respectively (Figure 1B). Electron microscopy images re-
vealed myopathic features in PGC-1α KO mice, evident
from the accumulation of multivesicular bodies, aberrant








































Figure 1 PGC-1α KO animals have lower mitochondrial content and d
weight. (B) Cytochrome C oxidase activity. (C) Representative images of CO
Representative images of SDH staining of EDL muscle from Con and Den W
PGC-1α KO muscle (top right and bottom two panels). PGC-1α KO animals
multivesicular bodies (top right), aberrant mitochondria (bottom left) as we
denervation. †P < 0.05, significant effect of genotype (n = 4 to 8 for all gro
knockout; TA, tibialis anterior; WT, wild type.These features are suggestive of autophagic deficiency in
animals lacking PGC-1α.
Attenuated autophagic signaling, lower lysosomal
abundance, and decreased denervation-induced autophagy
flux in mice lacking PGC-1α
We next set out to assess the role of the co-activator in
the transcriptional regulation of key autophagy genes and
in autophagy signaling, both basally and in response to de-
nervation. Denervation resulted in increased expression of
various genes that are involved in a variety of aspects of
autophagy and mitophagy. Significant increases in Park2,
Sqstm1, Maplc3b, Atg7, Lamp2, and Ctsd mRNA expres-
sion in response to denervation (Figure 2A) were ob-
served. We did not find a significant difference in the
mRNA expression of autophagic factors between WT and
KO animals, other than an attenuated denervation-
induced increase in Atg7. We also assessed autophagy sig-






























isplay myopathic features. (A) TA muscle mass corrected for body
X staining of EDL muscle from Con and Den WT and KO animals. (D)
T and KO animals. (E) EM images of control WT (top left panel) and
display a myopathic phenotype characterized by the accumulation of
ll as tubular aggregates (bottom right). *P < 0.05, significant effect of




















































































































































































Figure 2 (See legend on next page.)
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Figure 2 Lack of PGC-1α results in attenuation of autophagic signaling induced by denervation. (A) Autophagy gene expression measured by
real time PCR. mRNA fold change between wild type (WT) and PGC-1α KO (KO) control (Con) and denervated (Den). All groups were compared to WT
Con, and Gapdh and Actb were used as housekeeping genes. (B-G) Blots and quantification of autophagic proteins in control (C; Con), denervated (D;
Den) WT and KO animals. (B) Representative blots. Quantification of (C) parkin, (D) Beclin 1, (E) Atg7, (F) Cathepsin D and (G) Lamp-2. *P < 0.05 significant
difference between Con and Den. GAPDH was used as a loading control (n = 4 to 8 for all groups). AU, Arbitrary units; GAPDH, glyceraldehyde 3-
phosphate dehydrogenase.
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proteins in response to denervation (Figure 2B). Beclin1,
Atg7, Cathepsin D, and lysosome-associated membrane
protein 2 (Lamp-2) all increased, while parkin tended
to increase in WT animals (Figure 2B,C,D,E,F,G). Al-
though there was no significant difference in the
content of autophagy proteins between WT and KOLC3B I
II


















































































Figure 3 Lack of PGC-1α results in reduced lysososmal abundance an
quantification of autophagic proteins in control (Con), denervated (Den) WT, an
colchicine (col) for 4 days. (A) Representative blots. Quantification of (B) LC3BII
autophagy flux, and (F) denervation-induced autophagy flux, (G) Confocal ima
Lamp-2 (red) and colocalization is shown in yellow (Merge) and represents aut
significant difference between Con and Den. †P < 0.05 significant effect of gen
AU, arbitrary units; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; KO, knanimals basally, the denervation-induced increases in
Beclin1 and Lamp-2 levels were significantly attenuated
in KO muscle, while Cathepsin D induction tended to
be lower in KO animals.
In order to ascertain the influence of PGC-1α on au-
tophagy flux, we treated the animals with the microtubule
















































d denervation-induced autophagy flux. (A-C) Blots and
d PGC-1α KO (KO) animals; treated with vehicle (water) or 0.4mg/kg/day
and (C) p62, (D) Representative blot and quantification of Nix, (E) basal
ges of fixed single fibers immuno-stained for LC3 (green) and lysosomal
ophagosomes within lysosomes. Nuclei are in blue (DAPI). *P < 0.05
otype. GAPDH was used as a loading control (n = 3 to 5 for all groups).


































































































































































Figure 4 (See legend on next page.)
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Figure 4 Lack of PGC-1α results in attenuated mitophagy flux. (A-D) Blots and quantification of autophagic proteins in isolated mitochondrial
fractions in control (Con), denervated (Den) WT, and PGC-1α KO (KO) animals treated with vehicle (water) or colchicine (col) 0.4mg/kg/day for 4 days.
(A) Representative blots. Quantification of (B) LC3BII and (C) p62. (D) Representative blots. Quantification of mitochondrial (E) ubiquitin, (F) parkin, (G)
basal mitophagy flux, and (H) denervation-induced mitophagy flux. (I) Confocal images of fixed single fibers immuno-stained for cytochrome c (as a
mitochondrial marker, green) and lysosomal Lamp-2 (red); their colocalization (yellow) represents mitochondria within lysosomes. *P < 0.05 significant
difference between Con and Den. †P < 0.05 significant effect of genotype. VDAC was used as loading control (n = 3 to 5 for all groups). AU, arbitrary
units; KO, knockout; VDAC, voltage-dependent anion channel; WT, wild type.
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nervation resulted in increased accumulation of LC3B-II,
p62, and Nix (Bnip3l) proteins in WT muscle. Colchicine
treatment resulted in further accumulations of LC3B-II and
p62 in denervated WT muscle, indicating a successful block
in autophagic degradation with the drug (Figure 3A,B,C).
In contrast, PGC-1α KO animals exhibited an attenuated
LC3B-lipidation and expression of the mitophagy-specific
receptor Nix both basally and in response to denervation
(Figure 3A,B,D). No significant difference in p62 expression
was observed basally between the genotypes, and p62 levels
did not change in KO animals with either Den or Col treat-
ment (Figure 3C). Importantly, both basal and denervation-
induced p62 and LC3B-II flux were lower in KO animals,
as evidenced by a smaller accumulation of LC3BII and p62
in KO animals treated with colchicine (Figure 3E,F). We
further examined lysosomal abundance and autophagy flux
in KO and WT animals using confocal microscopy (Fig-
ure 3G). We did this by isolating single fibers from fixed
EDL muscles and co-immunostaining them for LC3B and
Lamp-2. KO animals had lower lysosomal abundance, as
indicated by a diminished intensity and frequency of
red fluorescence, and this was especially evident follow-
ing denervation (Figure 3G and Additional file 1: Figure
S2). We also noted an increase in the colocalization
(yellow) of autophagosomes and lysosomes and their
aggregation in the perinuclear region of denervated
WT muscles (Figure 3G, Merge). This was not as evi-
denced in the denervated KO muscle, as indicated by
decreased yellow flourescence. Taken together, these re-
sults indicate that the lack of PGC-1α results in lower
lysosomal abundance and reduced autophagy flux in re-
sponse to denervation.
Mitophagy is attenuated in PGC-1α-deficient muscle
Since PGC-1α is a major metabolic regulator that plays
a key role in mitochondrial homeostasis, we were inter-
ested in elucidating the role of this co-activator in mito-
chondrial removal by mitophagy. During denervation,
the mitochondrial pool within skeletal muscle undergoes
a substantial reduction (33% to 42%, Figure 1B). To de-
termine the involvement of PGC-1α in mitophagy, we
isolated mitochondria from both the denervated and con-
trol gastrocnemius muscle of WT and KO animals that
were treated with either vehicle or colchicine (Figure 4).Denervation resulted in an increase in the localization of
LC3BII, p62, and parkin to the mitochondria, as well as an
elevated overall ubiquitination of mitochondrial substrates
(Figure 4A,B,C,D,E), culminating in increased mitophagy
flux (Figure 4H). These findings indicate that mitophagy is
involved in the removal of mitochondria from the muscle
basally and during denervation. This response was re-
duced in the KO animals (Figure 4G,H,I). The muscle
from KO animals exhibited similar basal localization of
autophagic proteins to the mitochondria (Figure 4A,B,C,
D,E,F) but had an attenuated increase in mitochondrial
localization of these proteins with denervation. Im-
portantly, KO animals exhibited lower basal and
denervation-induced mitophagy flux (Figure 4G,H).
To further investigate mitophagy flux, we co-stained
the isolated single EDL fibers with mitochondrial cyto-
chrome c (Cyto C; green) as well as with Lamp-2 (red)
and assessed their co-localization (Merge; yellow) using
confocal microscopy (Figure 4I). The images suggest a de-
crease in the co-localization of mitochondria with lyso-
somes in denervated KO animals compared to WT
animals, further supporting a decrease in mitophagy flux
in the KO animals in response to denervation.
TFEB protein levels are induced with denervation
and may mediate PGC-1α action on autophagy
To examine the role of PGC-1α in the expression of au-
tophagy genes, we examined TFEB, the master transcrip-
tional regulator of the autophagy-lysosome system, as
several recent studies have indicated an interplay be-
tween these two factors [16,17,28,29]. TFEB protein
levels were increased with denervation in WT animals
(Figure 5A,B,C), and this tended to impact the levels of
TFEB in the nucleus. In the KO animals, TFEB levels and
nuclear localization were lower under basal conditions
(P < 0.05) and did not change in response to denervation
(Figure 5A,B,C).
Overexpression of PGC-1α results in increased mitochondrial
content and protection from denervation-induced
mitochondrial loss and muscle atrophy
Since our results indicate a potential role for PGC-1α
in regulating autophagy flux in response to denerv-
ation, we investigated whether PGC-1α alone was suffi-

















































Figure 5 Lack of PGC-1α results in lower TFEB protein levels
and nuclear localization. (A-C) Blots and quantification TFEB
protein levels between wild type (WT) and PGC-1α KO (KO) control
(Con) and denervated (Den). (A) Representative blots. Quantification of
(B) whole muscle TFEB protein. (C) Nuclear localization of TFEB in TA
muscle. *P < 0.05 significant difference between Con and Den. †P <
0.05 significant effect of genotype. GAPDH was used as loading control
for whole muscle, and histone 2 B (H2B) was used as nuclear loading
control (n = 4 to 8 for all groups). GAPDH, glyceraldehyde
3-phosphate dehydrogenase; Nuc. H2B, nuclear histone 2B; Nuc. TFEB,
nuclear transcription factor EB; TFEB, nuclear transcription factor EB.
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muscle from Tg animals displayed a much more oxidative
phenotype (Figure 6C,D), and they were protected from
denervation-induced muscle atrophy (Figure 6A). We con-
firmed PGC-1α over-expression in Tg animals by immuno-
blotting for PGC-1α (Figure 6B) and COXIV (Figure 6C), a
downstream target of the co-activator, as well as withhistochemical staining for SDH (Figure 6D). The TA mus-
cles of Tg animals were significantly richer in mitochondria
and exhibited a reduced loss of mitochondrial content in
response to denervation, as indicated by greater COXIV
protein (Figure 6C) and darker SDH staining (Figure 6D),
compared to WTcontrols.
PGC-1α overexpression increases lysosomal and
mitophagy receptor expression
We examined the effect of PGC-1α overexpression on the
levels of autophagy genes and proteins basally and in re-
sponse to denervation. Real-time PCR analyses confirmed
that 7 days of denervation resulted in increased expression
of various autophagy and mitophagy genes, such as Park2,
Sqstm1, Maplc3b, Atg7, and Ctsd (Figure 7A) consistent
with our earlier results (Figure 2A). We found a decrease
(P < 0.05) in the basal expression of Sqstm1, Bnip3l, and
Atg7 in Tg animals. In addition, we also observed attenu-
ated denervation-induced increases in Sqstm1, Maplc3b,
and Atg7. We also assessed autophagy signaling by west-
ern blot analysis. Parkin, Beclin1, and Atg7 protein levels
were similar in WT and Tg animals, both basally and in
response to denervation (Figure 7B,C,D,E). However, the
levels of the lysosomal proteins Cathepsin D and Lamp-2
were significantly higher in Tg as compared to WT ani-
mals, and these were markedly increased in the dener-
vated Tg muscle (Figure 7F,G). Tg animals also displayed
significantly higher levels of both LC3I and II than WT
controls, and these were augmented to a greater extent by
denervation compared to WT animals (Figure 8A,B,C).
Similarly, Nix protein content was higher in Tg, as com-
pared to WT animals, both basally and in response to de-
nervation (Figure 8D), while p62 levels were similar in
both genotypes (Figure 8E). Taken together, these data
suggest that PGC-1α selectively induces the expression of
specific autophagy and lysosomal proteins.
PGC-1α overexpression resulted in reduced autophagy
markers in the mitochondrial subfraction
Since we found a protective effect of PGC-1α overexpres-
sion on mitochondria following denervation (Figure 6), we
wanted to investigate whether mitophagy was affected.
Our results indicate that PGC-1α overexpression leads to
a decreased localization of LC3BII and p62 to the mito-
chondrial fraction in Tg muscle, both basally and in re-
sponse to denervation (Figure 9A,B,C).
TFEB is induced with denervation and may mediate
PGC-1α action on autophagy
Since we found a decrease in TFEB protein levels in ani-
mals lacking PGC-1α (Figure 5), we further investigated
the effects of PGC-1α overexpression on this transcrip-
tion factor. TFEB protein levels were significantly higher


























































Figure 6 PGC-1α over-expressing animals have higher mitochondrial content and are protected from denervation-induced muscle
atrophy. (A) TA muscle mass corrected for body weight. (B) PGC-1α blot confirming overexpression in TA muscle. (C) Representative blot and
quantification of COXIV as a mitochondrial content marker. (D) Representative images of SDH staining of TA muscle from Con and Den WT and Tg
animals. *P < 0.05, significant effect of denervation. †P < 0.05, significant effect of genotype (n = 3 to 5 for all groups). Con, control; Den, denervated;
GAPDH, glyceraldehyde 3-phosphate dehydrogenase; PGC-1α, peroxisome proliferator co-activator 1 alpha; TA, tibialis anterior; Tg, transgenic; WT,
wild type.
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animals, to a level that was similar to the higher basal level
evident in Tg animals (Figure 10A,B). TFEB protein was
not further induced by denervation in Tg animals.
Discussion
Metabolic plasticity is a unique property which permits the
fine tuning of energy production to meet energy demands
in skeletal muscle, allowing for adaptations in response to
alterations in nutrient availability, hormonal stimuli, and
contractile activity. This property makes muscle a pillar of
whole-body homeostasis, in particular during energetic dis-
tress. Interestingly, both the autophagy-lysosome system
and the transcriptional co-activator PGC-1α have been
separately documented to contribute to whole-body meta-
bolic homeostasis, as well as to muscle plasticity, in re-
sponse to alterations in nutrient availability and contractile
activity [10,15,29-34]. However, the role of PGC-1α in au-
tophagy and mitophagy has not been dissected thus far. In
this study, we illuminate a role for PGC-1α in autophagy
and mitophagy in skeletal muscle in response to chronic
muscle disuse. Moreover, we identify the transcription fac-
tor TFEB to be a potential target of PGC-1α in the regula-
tion of autophagy in this tissue.
Our results have confirmed the myopathic phenotype
evident in muscles of animals lacking PGC-1α. Themuscle of KO animals was characterized by a diminished
mitochondrial content, smaller cross-sectional area, and
an accumulation of damaged organelles and multivesicu-
lar bodies as evidenced by the appearance of abnormal
structures in EM images. Some of the myopathic features
of PGC-1α KO muscle are reminiscent of those found in
autophagy-deficient animals which also exhibit deficient
mitochondria and increased apoptosis [10,35,36]. We did
not note a basal difference between WT and KO animals
in the mRNA or protein expression of various autophagy
markers. However, it is possible that an earlier time point
following the onset of denervation, when autophagy gene
expression may have peaked, could have revealed some
endogenous expression differences between the two geno-
types in response to this muscle atrophy stimulus. Import-
antly, we did observe an attenuated induction in LC3B
lipidation and protein expression of lysosomal factor
Lamp-2 with denervation in KO animals. A lack of PGC-
1α also resulted in reduced basal as well as denervation-
induced autophagy flux, suggesting that the presence of
PGC-1α has a significant impact on the maintenance of
autophagy in muscle.
In contrast to the mitochondrial phenotype observed in
KO animals, over-expression of the co-activator resulted in
a highly oxidative muscle that was protected from
denervation-induced loss of mitochondria and muscle
TgWT









































































































































































Figure 7 (See legend on next page.)
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Figure 7 Over-expression of PGC-1α results in enhanced lysosomal protein expression induced by denervation. (A) Autophagy gene
expression. mRNA fold changes between wild type (WT) and PGC-1α Tg (Tg) control (Con) and denervated (Den). All groups are compared to WT
con, Gapdh and Actb were used as housekeeping genes. (B-G) Blots and quantification of autophagic proteins in Con, Den WT and Tg animals.
(B) Representative blots. Quantification of (C) Parkin, (D) Beclin 1, (E) Atg7, (F) Cathepsin D, and (G) Lamp-2. *P < 0.05 significant difference
between Con and Den. †P < 0.05, significant effect of genotype. GAPDH was used as a loading control (n = 3 to 5 for all groups). AU, arbitrary
units; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
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ing, as well as the increased COXIV protein expression in
Tg animals that did not decrease with denervation. This
protection has been previously documented to be a result
of improved mitochondrial function [37], cellular oxida-
tive status [38], and suppression of FoxO3-mediated ca-
tabolism [13]. Similar to our observations with KO
animals, overexpression of the coactivator did not result
in dramatic alterations in autophagy protein expression.
However, levels of the lysosomal marker Lamp-2 and the
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Figure 8 Elevated PGC-1α results in greater basal and denervation-in
of autophagic proteins in control (Con), denervated (Den) WT and PGC-1α
(C) LC3BII, (D) Nix, and (E) p62. *P < 0.05 significant difference between Co
as a loading control (n = 3 to 5 for all groups). AU, arbitrary units; GAPDH,animals and were further increased with denervation.
Moreover, LC3B protein levels, as well as LC3B lipidation
were both enhanced in the Tg animals, suggesting an in-
creased autophagy flux mediated by PGC-1α. In another
study involving the use of fasting as an inducer of autoph-
agy, we have confirmed the increase in autophagy flux in
Tg animals (Additional file 1: Figure S4).
To investigate the role of PGC-1α in mitophagy, we
examined the expression of the mitophagy receptor Nix
(Bnip3L) as well as the localization of autophagy factors






































duced autophagy protein expression. (A-E) Blots and quantification
Tg (Tg) animals. (A) Representative blots. Quantification of (B) LC3BI,































Figure 10 Elevated PGC-1α results in increased TFEB protein
levels. (A-B) Blots and quantification TFEB protein level in TA muscle
and in nuclear fraction of wild type (WT) and PGC-1α Tg (Tg) control
(Con) and denervated (Den). (A) Representative blots. (B) Quantification of
TFEB protein in TA muscle. *P < 0.05 significant difference between Con
and Den. †P < 0.05 significant effect of genotype. GAPDH was used as
loading control for whole muscle and histone 2 B (H2B) was used as
nuclear loading control (n = 3 to 5 for all groups). GAPDH, glyceraldehyde
3-phosphate dehydrogenase. H2B, histone 2 B; Nuc. TFEB, nuclear
transcription factor EB; TFEB, transcription factor EB.
p62
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Figure 9 PGC-1α Tg animals demonstrate lower presence of
autophagy markers in isolated mitochondria. (A-C) Blots and
quantification of autophagic proteins on isolated mitochondria in control
(Con), denervated (Den) WT and PGC-1α Tg (Tg). (A) Representative blots.
Quantification of (B) LC3BII and (C) p62. †P < 0.05 significant effect of
genotype. VDAC was used as loading control (n = 3 for all groups). AU,
arbitrary units; VDAC, voltage-dependent anion channel.
Vainshtein et al. Skeletal Muscle  (2015) 5:9 Page 13 of 17significantly reduced in KO, and strongly induced in Tg,
when compared to WT animals, indicating that Nix may
be under the control of PGC-1α. This could be mediated
by the PGC-1α-HIF-1α axis, as Nix was found to be
under HIF-1α control during hypoxia [39], and HIF-1α
was documented to be stabilized by PGC-1α in muscle
cells [40]. However, further research is required to con-
firm this interaction in muscle. We also noted an en-
hanced localization of LC3B-II, p62, parkin as well as
ubiquitin to isolated mitochondria with denervation in
WT animals, but this effect was attenuated in KO ani-
mals. Indeed, both basal and denervation-inducedmitophagy flux were reduced, indicating impaired mito-
phagy in the absence of PGC-1α. We have previously
documented oxygen consumption deficits and enhanced
susceptibility to apoptosis in mitochondria of the PGC-
1α KO muscle [18]. These findings can now likely be at-
tributed to deficient mitochondrial turnover, resulting
from a combination of an impairment in mitochondrial
biogenesis [1,19,41] as well as mitophagy in the absence
of PGC-1α.
Interestingly, we also noted reduced localization of au-
tophagic markers p62 and LC3B-II to the mitochondrial
fraction of Tg animals, both basally and in response to
denervation. This corresponded to the enhanced protec-
tion of mitochondrial content during denervation in
these animals, and it occurred despite increases in LC3B
and the mitophagy receptor Nix in whole muscle ex-
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Figure 11 Proposed relationship between PGC-1α expression, mitochondrial function, and mitophagy during cellular stress. (A-B) Upon
cellular metabolic stress such as denervation or nutrient deprivation lack of PGC-1α results in diminished mitochondrial function, biogenesis, and
impaired autophagy and mitophagy, whereas its overexpression results in superior mitochondrial function and biogenesis as well as enhanced
autophagy, but reduced mitophagy. (A) Hypothetical graphical representation of the relationship between levels of PGC-1α, mitochondrial
function, and mitophagy. (B) Schematic outlining mitochondrial turnover during denervation-induced metabolic stress in muscle in light of
variations in PGC-1α expression. Steady state mitochondrial content is represented in the center of each panel. In the presence of endogenous
PGC-1α levels (middle panel), biogenesis is active at a low level during denervation, but both mitophagy and autophagy flux are enhanced leading to a
reduced steady state mitochondrial content. When the expression of PGC-1α is abolished (upper panel), biogenesis is further reduced during denervation,
as are autophagy and mitophagy flux, leading to a smaller, dysfunctional pool of mitochondria. When PGC-1α levels are elevated (lower panel), biogenesis
is higher while mitophagy is lower than normal during denervation, leading to a maintained organelle content. Arrow thickness provides an indication of
the magnitude of the pathway. AAs, amino acids; PGC-1α, peroxisome proliferator co-activator 1 alpha; ROS, reactive oxygen species.
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WT littermates (Additional file 1: Figure S5). These data
suggest that PGC-1α mediates a reduced targeting of
mitochondria for mitophagy when mitochondrial func-
tion and content are high. Based on our data, we con-
tend that physiological levels of PGC-1α are required
for the proper propagation of mitophagy in muscle, as a
lack of PGC-1α results in reduced mitochondrial turn-
over, culminating in the accumulation of defective
mitochondria, increased susceptibility to cell death [18]
and overall muscle atrophy. In contrast, PGC-1α over-
expression is protective of mitochondrial mass via sev-
eral mechanisms (Figure 11A,B). First, PGC-1α has
been shown to improve mitochondrial function [42,43]
and enhance cellular antioxidant capability [38] which
can result in reduced mitochondrial targeting for deg-
radation. Second, mitochondrial fragmentation is re-
quired for mitophagy to occur, and PGC-1α augments
the expression of factors involved in mitochondrial fu-
sion such as mitofusin 1 and 2 [44], resulting in a more
reticular mitochondrial phenotype that can better evade
mitophagy. Third, PGC-1α overexpression has been
documented to block FoxO3-mediated transcriptional
activity [13], and since FoxO3 drives the expression of
multiple mitophagy factors such as Mul1 and Bnip3
[45,46], repression of FoxO3activity may be sufficient
to protect mitochondria from elimination.
The involvement of autophagy during denervation has
recently been brought into question. Some evidence has
indicated a block in autophagy early in denervation
[47,48], while other data point to the contrary at later
time points [10,21,22,46,49-51]. Here, we demonstrate
that autophagy and mitophagy flux were both elevated
at 7 days of denervation, with mitophagy contributing to
mitochondrial loss during disuse. Indeed, localization of
LC3B-II, p62, and parkin to the mitochondria were all
induced during denervation resulting in enhanced mito-
phagy flux in WT animals.
Our study has also revealed key evidence supporting
a role for PGC-1α in lysosomal biogenesis. Lack of
PGC-1α resulted in reduced denervation-induced lyso-
somal protein expression and overall lysosomal abun-
dance, while PGC-1α overexpression provoked an
increase in basal and denervation-induced levels of the
lysosomal proteins Lamp-2 and cathepsin D. Further-
more, we found a correlation (Pearson r = 0.84; data not
shown) between levels of PGC-1α and the lysosomal
master regulator TFEB. This further supports findings
by Scott et al. [17] on the coordinated regulation of
PGC-1α and TFEB, which works to ensure the proper
matching between mitochondrial removal and biogen-
esis. Thus, we highlight a role for PGC-1α in lysosomal
biogenesis which could be mediated, at least in part, by
TFEB.Conclusions
Our results suggest a role for the transcriptional
co-activator PGC-1α in the regulation of autophagy-
lysosomal machinery and mitophagy in skeletal muscle. A
lack of PGC-1α results in reduced disuse-induced autoph-
agy and mitophagy signaling and flux, whereas PGC-1α
overexpression increased lysosomal abundance and bulk
autophagy flux while suppressing mitophagy (Figure 11B)
Therefore, our findings elucidate a previously unidentified
role for PGC-1α in the fine tuning of autophagy and mito-
phagy in skeletal muscle, and the identification of pharma-
cological targets along the PGC-1α-autophagy axis could
be of therapeutic benefit to those suffering from metabolic
or muscle wasting myopathies.
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